<DOC>
	<DOCNO>NCT00234533</DOCNO>
	<brief_summary>The main purpose study establish optimal monitor regimen NutropinAq treat child , use newly develop capillary blood spot IGF-1 measurement technology .</brief_summary>
	<brief_title>Study Define Optimal IGF-1 Monitoring Children Treated With NutropinAq</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Pituitary Diseases</mesh_term>
	<criteria>Children 18 growth failure associate inadequate growth hormone secretion , Turner syndrome chronic renal insufficiency . Children close epiphysis Children active neoplasm Children acute critical illness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>growth</keyword>
	<keyword>child development</keyword>
	<keyword>growth hormone</keyword>
	<keyword>inadequate growth hormone secretion</keyword>
	<keyword>growth failure</keyword>
</DOC>